과제정보
This study was supported by a grant from the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is part of the Korea Healthcare Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea (Grant No.: A103001).
참고문헌
- Davenport, F. M., A. V. Hennessy, and T. Francis, Jr. 1953. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. Exp. Med. 98: 641-656. https://doi.org/10.1084/jem.98.6.641
- Taylor, A., S. S. Foo, R. Bruzzone, L. V. Dinh, N. J. King, and S. Mahalingam. 2015. Fc receptors in antibody-dependent enhancement of viral infections. Immunol. Rev. 268: 340-364. https://doi.org/10.1111/imr.12367
- McHeyzer-Williams, M., S. Okitsu, N. Wang, and L. Heyzer- Williams. 2012. Molecular programming of B cell memory. Nat. Rev .Immunol. 12: 24-34. https://doi.org/10.1038/nri3128
- Netea, M. G., L. A. Joosten, E. Latz, K. H. Mills, G. Natoli, H. G. Stunnenberg, L. A. O'Neill, and R. J. Xavier. 2016. Trained immunity: A program of innate immune memory in health and disease. Science 352: aaf1098.
- Okhrimenko, A., J. R. Grun, K. Westendorf, Z. Fang, S. Reinke, R. P. von, G. Wassilew, A. A. Kuhl, R. Kudernatsch, S. Demski, C. Scheibenbogen, K. Tokoyoda, M. A. McGrath, M. J. Raftery, G. Schonrich, A. Serra, H. D. Chang, A. Radbruch, and J. Dong. 2014. Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory. Proc. Natl. Acad. Sci. U. S. A. 111: 9229-9234. https://doi.org/10.1073/pnas.1318731111
- Rothman, A. L. 2011. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 11: 532-543. https://doi.org/10.1038/nri3014
- Beverley, P. C. 2002. Immunology of vaccination. Br. Med. Bull. 62: 15-28. https://doi.org/10.1093/bmb/62.1.15
- Tangye, S. G., D. T. Avery, E. K. Deenick, and P. D. Hodgkin. 2003. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J. Immunol. 170: 686-694. https://doi.org/10.4049/jimmunol.170.2.686
- Michie, C. A., A. McLean, C. Alcock, and P. C. Beverley. 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360: 264-265. https://doi.org/10.1038/360264a0
- Swain, S. L. 2000. CD4 T-cell memory can persist in the absence of class II. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355: 407-411. https://doi.org/10.1098/rstb.2000.0581
- Hale, J. S., and R. Ahmed. 2015. Memory T follicular helper CD4 T cells. Front. Immunol. 6: 16.
- Schmidlin, H., S. A. Diehl, and B. Blom. 2009. New insights into the regulation of human B-cell differentiation. Trends Immunol. 30: 277-285. https://doi.org/10.1016/j.it.2009.03.008
- Benson, M. J., L. D. Erickson, M. W. Gleeson, and R. J. Noelle. 2007. Affinity of antigen encounter and other early B-cell signals determine B-cell fate. Curr. Opin. Immunol. 19: 275-280. https://doi.org/10.1016/j.coi.2007.04.009
- Lees, J. R., and D. L. Farber. 2010. Generation, persistence and plasticity of CD4 T-cell memories. Immunology 130: 463-470. https://doi.org/10.1111/j.1365-2567.2010.03288.x
- Ma, C. S., E. K. Deenick, M. Batten, and S. G. Tangye. 2012. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209: 1241-1253. https://doi.org/10.1084/jem.20120994
- Eisen, H. N. 2014. Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses. Cancer Immunol. Res. 2: 381-392. https://doi.org/10.1158/2326-6066.CIR-14-0029
- Farrington, L. A., T. A. Smith, F. Grey, A. B. Hill, and C. M. Snyder. 2013. Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection. J. Immunol. 190: 3410-3416. https://doi.org/10.4049/jimmunol.1203151
- Johansson, B. E., and E. D. Kilbourne. 1996. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Virology 225: 136-144. https://doi.org/10.1006/viro.1996.0581
- Pham, G. H., B. V. Iglesias, and E. J. Gosselin. 2014. Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells. Vaccine 32: 5212-5220. https://doi.org/10.1016/j.vaccine.2014.07.050
- Krammer, F., P. Palese, and J. Steel. 2015. Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr. Top. Microbiol. Immunol. 386: 301-321. https://doi.org/10.1007/82_2014_408
- Nachbagauer, R., T. J. Wohlbold, A. Hirsh, R. Hai, H. Sjursen, P. Palese, R. J. Cox, and F. Krammer. 2014. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. J. Virol. 88: 13260-13268. https://doi.org/10.1128/JVI.02133-14
- Adar, Y., Y. Singer, R. Levi, E. Tzehoval, S. Perk, C. Banet- Noach, S. Nagar, R. Arnon, and T. Ben-Yedidia. 2009. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 27: 2099-2107. https://doi.org/10.1016/j.vaccine.2009.02.011
- Hemann, E. A., S. M. Kang, and K. L. Legge. 2013. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination. J. Immunol. 191: 2486-2494. https://doi.org/10.4049/jimmunol.1300954
- Zeng, W., A. C. Tan, K. Horrocks, and D. C. Jackson. 2015. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. Vaccine 33: 3526-3532. https://doi.org/10.1016/j.vaccine.2015.05.053
- Gibbons, R. V. 2010. Dengue conundrums. Int. J. Antimicrob. Agents 36 Suppl 1: S36-S39. https://doi.org/10.1016/j.ijantimicag.2010.06.019
- Weiskopf, D., and A. Sette. 2014. T-cell immunity to infection with dengue virus in humans. Front. Immunol. 5: 93.
- McKittrick, N., I. Frank, J. M. Jacobson, C. J.W hite, D. Kim, R. Kappes, C. DiGiorgio, T. Kenney, J. Boyer, and P. Tebas. 2013. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann. Intern. Med. 158: 19-26. https://doi.org/10.7326/0003-4819-158-1-201301010-00005
- Berger, C. T., V. Greiff, M. Mehling, S. Fritz, M. A. Meier, G. Hoenger, A. Conen, M. Recher, M. Battegay, S. T. Reddy, and C. Hess. 2015. Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection. Hum. Vaccin. Immunother. 11: 391-396. https://doi.org/10.1080/21645515.2015.1008930
- Sallusto, F., A. Lanzavecchia, K. Araki, and R. Ahmed. 2010. From vaccines to memory and back. Immunity 33: 451-463. https://doi.org/10.1016/j.immuni.2010.10.008
- Tricco, A. C., A. Chit, C. Soobiah, D. Hallett, G. Meier, M. H. Chen, M. Tashkandi, C. T. Bauch, and M. Loeb. 2013. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 11: 153.
- Johns, M. C., A. A. Eick, D. L. Blazes, S. E. Lee, C. L. Perdue, R. Lipnick, K. G. Vest, K. L. Russell, R. F. DeFraites, and J. L. Sanchez. 2010. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5: e10722.
- Eick-Cost, A. A., K. J. Tastad, A. C. Guerrero, M. C. Johns, S. E. Lee, V. H. Macintosh, R. L. Burke, D. L. Blazes, K. L. Russell, and J. L. Sanchez. 2012. Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach. PLoS One 7: e41435.
- Bergtold, A., D. D. Desai, A. Gavhane, and R. Clynes. 2005. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23: 503-514. https://doi.org/10.1016/j.immuni.2005.09.013
- Batista, F. D., and M. S. Neuberger. 2000. B cells extract and present immobilized antigen: implications for affinity discrimination. EMBO J. 19: 513-520. https://doi.org/10.1093/emboj/19.4.513
- Faix, D. J., A. W. Hawksworth, C. A. Myers, C. J. Hansen, R. G. Ortiguerra, R. Halpin, D. Wentworth, L. A. Pacha, E. G. Schwartz, S. M. Garcia, A. A. Eick-Cost, C. D. Clagett, S. Khurana, H. Golding, and P. J. Blair. 2012. Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses. PLoS One 7: e34581.
- Skowronski, D. M., N. Z. Janjua, S. G. De, S. Sabaiduc, A. Eshaghi, J. A. Dickinson, K. Fonseca, A. L. Winter, J. B. Gubbay, M. Krajden, M. Petric, H. Charest, N. Bastien, T. L. Kwindt, S. M. Mahmud, C. P. Van, and Y. Li. 2014. Low 2012- 13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 9: e92153.
- Chambers, B. S., K. Parkhouse, T. M. Ross, K. Alby, and S. E. Hensley. 2015. Identification of hemagglutinin residues responsible for H3N2 antigenic drift during the 2014-2015 influenza season. Cell Rep. 12: 1-6. https://doi.org/10.1016/j.celrep.2015.06.005
- Hancock, K., V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, T. L. Brammer, N. J. Cox, T. M. Tumpey, and J. M. Katz. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361: 1945-1952. https://doi.org/10.1056/NEJMoa0906453
- Dormitzer, P. R., G. Galli, F. Castellino, H. Golding, S. Khurana, G. G. Del, and R. Rappuoli. 2011. Influenza vaccine immunology. Immunol. Rev. 239: 167-177. https://doi.org/10.1111/j.1600-065X.2010.00974.x
- Neumann, G., and Y. Kawaoka. 2011. The first influenza pandemic of the new millennium. Influenza Other Respir. Viruses 5: 157-166. https://doi.org/10.1111/j.1750-2659.2011.00231.x
- Tan, G. S., P. E. Leon, R. A. Albrecht, I. Margine, A. Hirsh, J. Bahl, and F. Krammer. 2016. Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection. PLoS Pathog. 12: e1005578.
- Viboud, C., J. Eisenstein, A. H. Reid, T. A. Janczewski, D. M. Morens, and J. K. Taubenberger. 2013. Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky. J. Infect. Dis. 207: 721-729. https://doi.org/10.1093/infdis/jis745
- Reed, C., S. S. Chaves, A. Perez, T. D'Mello, K. P. Daily, D. Aragon, J. I. Meek, M. M. Farley, P. Ryan, R. Lynfield, C. A. Morin, E. B. Hancock, N. M. Bennett, S. M. Zansky, A. Thomas, M. L. Lindegren, W. Schaffner, and L. Finelli. 2014. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin. Infect. Dis. 59: 166-174. https://doi.org/10.1093/cid/ciu285
- Morens, D. M., J. K. Taubenberger, G. K. Folkers, and A. S. Fauci. 2010. Pandemic influenza's 500th anniversary. Clin. Infect. Dis. 51: 1442-1444. https://doi.org/10.1086/657429
- Tumpey, T. M., C. F. Basler, P. V. Aguilar, H. Zeng, A. Solorzano, D. E. Swayne, N. J. Cox, J. M. Katz, J. K. Taubenberger, P. Palese, and A. Garcia-Sastre. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310: 77-80. https://doi.org/10.1126/science.1119392
- Epstein, S. L., C. Y. Lo, J. A. Misplon, and J. R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160: 322-327. https://doi.org/10.4049/jimmunol.160.1.322
- Zaiss, D. M., C. J. Boog, E. W. van, and A. J. Sijts. 2010. Considerations in the design of vaccines that induce CD8 T cell mediated immunity. Vaccine 28: 7716-7722. https://doi.org/10.1016/j.vaccine.2010.08.101
- Murali-Krishna, K., L. L. Lau, S. Sambhara, F. Lemonnier, J. Altman, and R. Ahmed. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286: 1377-1381. https://doi.org/10.1126/science.286.5443.1377
- Shane, H. L., and K. D. Klonowski. 2014. Every breath you take: the impact of environment on resident memory CD8 T cells in the lung. Front. Immunol. 5: 320.
- Liang, S., K. Mozdzanowska, G. Palladino, and W. Gerhard. 1994. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152: 1653-1661. https://doi.org/10.4049/jimmunol.152.4.1653
- Wu, T., Y. Hu, Y. T. Lee, K. R. Bouchard, A. Benechet, K. Khanna, and L. S. Cauley. 2014. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J. Leukoc. Biol. 95: 215-224. https://doi.org/10.1189/jlb.0313180
- Kash, J. C., T. M. Tumpey, S. C. Proll, V. Carter, O. Perwitasari, M. J. Thomas, C. F. Basler, P. Palese, J. K. Taubenberger, A. Garcia-Sastre, D. E. Swayne, and M. G. Katze. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581. https://doi.org/10.1038/nature05181
- Taubenberger, J. K., and D. M. Morens. 2008. The pathology of influenza virus infections. Annu. Rev. Pathol. 3: 499-522. https://doi.org/10.1146/annurev.pathmechdis.3.121806.154316
- Schmid, M. A., M. S. Diamond, and E. Harris. 2014. Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front. Immunol. 5: 647.
- Avirutnan, P., P. Malasit, B. Seliger, S. Bhakdi, and M. Husmann. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161: 6338-6346. https://doi.org/10.4049/jimmunol.161.11.6338
- Dalrymple, N., and E. R. Mackow. 2011. Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J. Virol. 85: 9478-9485. https://doi.org/10.1128/JVI.05008-11
- Ghebrehiwet, B., and E. I. Peerschke. 2004. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multiligand binding cellular proteins involved in inflammation and infection. Mol. Immunol. 41: 173-183. https://doi.org/10.1016/j.molimm.2004.03.014
- Dalrymple, N. A., and E. R. Mackow. 2014. Virus interactions with endothelial cell receptors: implications for viral pathogenesis. Curr. Opin. Virol. 7: 134-140. https://doi.org/10.1016/j.coviro.2014.06.006
- Thomas, K. A., N. M. Valenzuela, and E. F. Reed. 2015. The perfect storm: HLA antibodies, complement, FcgammaRs, and endothelium in transplant rejection. Trends Mol. Med. 21: 319-329. https://doi.org/10.1016/j.molmed.2015.02.004
- Beltramello, M., K. L. Williams, C. P. Simmons, A. Macagno, L. Simonelli, N. T. Quyen, S. Sukupolvi-Petty, E. Navarro-Sanchez, P. R. Young, A. M. de Silva, F. A. Rey, L. Varani, S. S. Whitehead, M. S. Diamond, E. Harris, A. Lanzavecchia, and F. Sallusto. 2010. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8: 271-283. https://doi.org/10.1016/j.chom.2010.08.007
- Short, K. R., E. J. Veldhuis Kroeze, L. A. Reperant, M. Richard, and T. Kuiken. 2014. Influenza virus and endothelial cells: a species specific relationship. Front. Microbiol. 5: 653.
- Monsalvo, A. C., J. P. Batalle, M. F. Lopez, J. C. Krause, J. Klemenc, J. Z. Hernandez, B. Maskin, J. Bugna, C. Rubinstein, L. Aguilar, L. Dalurzo, R. Libster, V. Savy, E. Baumeister, L. Aguilar, G. Cabral, J. Font, L. Solari, K. P. Weller, J. Johnson, M. Echavarria, K. M. Edwards, J. D. Chappell, J. E. Crowe, Jr., J. V. Williams, G. A. Melendi, and F. P. Polack. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17: 195-199. https://doi.org/10.1038/nm.2262